Brain steroids are associated with AD as they offer neuroprotection against pathogenic DAT factors like Aβ and against tau pathology, mitochondrial impairment, neuroinflammation, impaired neurogenesis and memory loss [55], consistent with our results. Here, SLC6A3 is linked to Alzheimer disease.